Skip to content
Home/Companies/Biotech/Philogen
PH

Philogen

Biotech·Italy·Exited 2021·Held 2yr

Philogen is a biotech company, headquartered in Italy.

Entry
2019
Hold
2yr
Exit
2021
Est. EV
–

Who owns Philogen?

Philogen was owned by The Equity Club through The Equity Club (2018 vintage) from 2019 to 2021, exited via IPO.

Hand-verified · updated 2026-07-24

The Equity Club
Investor
The Equity Club
The Equity Club · 2018 · Private Equity

Key facts

HQItaly
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2021

More from The Equity Club

Other portfolio companies in the same fund.

Korus
Active
IndustrialsItaly· 2023
Regi
Active
ConsumerItaly· 2023
Art Group
Active
IndustrialsItaly· 2022
CY4Gate
Active
CybersecurityItaly· 2021
HSA Cosmetics
Active
ConsumerItaly· 2021
Lincotek
Active
IndustrialsItaly· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings